Form D · Pharmaceuticals
Verastem, Inc.
Needham, MA · CIK 0001526119
Offering snapshot reported Mar 6, 2020 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2020 | Initial | $100,000,000 | No comparison | 21 | SEC filing |
| Jan 7, 2020 | Initial | $4,829,628 | No comparison | 4 | SEC filing |
| Mar 6, 2014 | Initial | $3,898,326 | No comparison | 1 | SEC filing |
| Jul 19, 2012 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Nov 21, 2011 | Amendment | $20,402,606 | $299,997vs Nov 10, 2011 | 36 | SEC filing |
| Nov 10, 2011 | Initial | $20,102,609 | No comparison | 34 | SEC filing |
| Jul 26, 2011 | Initial | $32,050,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $6M
- Finders' fees
- $0
- Form D file number
- 021-362169
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JEFFERIES LLC | 2347 | |
| H.C.WAINWRIGHT & CO., LLC | 375 | |
| CANTOR FITZGERALD & CO. | 134 |
Source: Form D, filed Mar 6, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Aldrich | Director |
| Timothy Barberich | Director |
| Paul Brannelly | Executive |
| Cathy Carew | Executive |
| Amy C. Cavers | Executive |
| John K. Clarke | Director |
| Gina Consylman | Director |
| Robert Forrester | Director, Executive |
| Ansbert Gadicke | Director |
| Rob Gagnon | Executive |
| John Green | Executive |
| Piyush Gupta | Director |
| Joanna Horobin | Executive |
| Michael Kauffman | Director |
| Stephen Kraus | Director |
| Alison Lawton | Director |
| Jonathan Pachter | Executive |
| Dan Paterson | Executive |
| Louise Phanstiel | Director |
| Eric Rowinsky | Director |
| Stephen Sherwin, M.D. | Director |
| Monica Singh | Executive |
| Brian Stuglik | Director, Executive |
| Henri Termeer | Director |
| Bruce Wendel | Director |
| Christoph Westphal | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
117 Kendrick Street Suite 500
Needham, MA, 02494
Needham, MA, 02494